WALTHAM, Mass.–(BUSINESS WIRE)–Viridian Therapeutics, Inc. (Nasdaq: VRDN), a biotechnology company focused on discovering, developing and commercializing potential best-in-class medicines for serious and rare diseases, today reported recent business …
Author: Business Wire
National Vision Holdings, Inc. Reports Second Quarter 2025 Financial Results
DULUTH, Ga.–(BUSINESS WIRE)–National Vision Holdings, Inc. (NASDAQ: EYE) (“National Vision,” “we,” “our,” “us” or the “Company”) today reported its financial results for the second quarter ended June 28, 2025. “Our strong performance this quarter ref…
Alcon Agrees to Acquire STAAR Surgical
GENEVA & LAKE FOREST, Calif.–(BUSINESS WIRE)–Alcon Agrees to Acquire STAAR Surgical
Alcon Agrees to Acquire STAAR Surgical
GENEVA & LAKE FOREST, Calif.–(BUSINESS WIRE)–Alcon Agrees to Acquire STAAR Surgical
Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
WALTHAM, Mass.–(BUSINESS WIRE)–Viridian Therapeutics, Inc. (Nasdaq: VRDN), a biopharmaceutical company focused on discovering, developing, and commercializing potential best-in-class medicines for serious and rare diseases, today announced that the C…
Tenpoint Therapeutics Ltd. to Participate in Upcoming Investor Conferences in August
LONDON & SEATTLE–(BUSINESS WIRE)–Tenpoint Therapeutics, Ltd., a global, commercial-ready biotechnology company focused on developing groundbreaking treatments to rejuvenate vision in the aging eye, today announced that the Company will participate in…
Genentech’s Susvimo Maintains Vision Over Five Years With Two Refills Per Year in People With Wet Age-Related Macular Degeneration (AMD)
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today new, five-year efficacy, safety and durability data from the Phase III Portal study, a long-term extension of the Phase I…
STAAR Surgical to Host Second Quarter 2025 Earnings Conference Call and Webcast on August 6, 2025
LAKE FOREST, Calif.–(BUSINESS WIRE)–STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today announced that it will release financial results f…
iCare World USA Appoints Dawna Owens as Director of Strategic Partnerships
RALEIGH, N. C.–(BUSINESS WIRE)– #Ophthalmology–Dawna Owens joins iCare USA as Director of Strategic Partnerships, strengthening alliances across healthcare and enterprise sectors.
Glaukos Announces Second Quarter 2025 Financial Results
ALISO VIEJO, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced financ…
Stanton Optical Launches Advanced Eye Health Services Across 35 U.S. Locations
DELRAY BEACH, Fla.–(BUSINESS WIRE)–Stanton Optical, a leading retail brand under Now Optics and a national leader in affordable, full-service eye care, is expanding on-site clinical services to 35 locations nationwide in partnership with Physicians E…
National Vision Releases Annual Sustainability Report Highlighting 2024 Progress
DULUTH, Ga.–(BUSINESS WIRE)–National Vision, Inc., one of the largest optical retail companies in the U.S., released its 2024 Sustainability Report, “A World Worth Seeing.” The report focuses on the company’s performance across its Social, Employees,…
Bausch + Lomb Announces Second-Quarter 2025 Results
VAUGHAN, Ontario–(BUSINESS WIRE)–Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced its second-quarter 2025 financial results. “Our continued growth s…
betterview franchit le cap des 20 000 yeux traités en quatre ans
WINTERTHUR, Suisse–(BUSINESS WIRE)–betterview, un fournisseur suisse de chirurgie réfractive, a annoncé qu’il avait atteint le cap des 20 000 yeux traités depuis sa création en 2021. Depuis son lancement, l’entreprise a construit un réseau de dix cli…
National Vision Celebrates 11 Years of Supporting NOSA Students with $7,000 in Scholarships
DULUTH, Ga.–(BUSINESS WIRE)–National Vision, Inc., one of the nation’s largest optical retailers providing quality, affordable eye care and eyewear, has awarded $7,000 in scholarships to three optometry students whose passion for community impact and…
Bausch + Lomb Announces Publication of Phase 3 Data on LUMIFY® Preservative Free Redness Reliever Eye Drops
VAUGHAN, Ontario–(BUSINESS WIRE)–Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced Ophthalmology and Therapy has published results from a phase 3 stu…
Exonate plans ‘CLEAR-DE’ Phase IIb clinical trial of lead candidate EXN407 for diabetic eye disease
CAMBRIDGE, England–(BUSINESS WIRE)–Exonate Ltd., a biotechnology company developing novel, non-invasive, small-molecule therapeutics for patients with retinal vascular diseases, today announced plans to initiate a Phase IIb clinical trial for its lea…
betterview Reaches 20,000 Eyes Treated in Four Years
WINTERTHUR, Switzerland–(BUSINESS WIRE)–betterview, a Swiss provider of refractive eye surgery, has announced that it has reached the milestone of 20,000 eyes treated since its founding in 2021. Since its launch, the company has built a network of te…
betterview verzeichnet 20'000 behandelte Augen in vier Jahren
WINTERTHUR, Schweiz–(BUSINESS WIRE)–betterview, ein Anbieter für refraktive Chirurgie in der Schweiz, gibt bekannt, dass das Unternehmen die Marke von 20’000 behandelten Augen erreicht hat. Der Meilenstein wurde seit der Gründung des Unternehmens im …
Eye Spear Analysis Report 2025-2032 | Company Profiles, Product Details, Pictures, Recent Developments and Key Market Dynamics – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Eye Spear Market (By Product Type, Segment, Application, End-User, Sales Channel, Regional Analysis), Company Profiles, Eye Spear Product Details, Pictures, Recent Developments and Market Dynamics – Global Forecast (2025 -…